CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
Abstract Recently, the focus of enhancing tumor radiosensitivity has shifted from chemotherapeutics to targeted therapies. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are a novel class of selective cell cycle therapeutics that target the cyclin D-CDK4/6 complex and induce G1 phase arrest. Th...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2020-09-01
|
| Серии: | Journal of Experimental & Clinical Cancer Research |
| Предметы: | |
| Online-ссылка: | http://link.springer.com/article/10.1186/s13046-020-01693-w |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|